Flexible use of nuclear import pathways by HIV-1

HIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the retroviral preintegration complex (PIC), into the nucleus. Too large for passive diffusion through nuclear pore complexes (NPCs), PICs use cellular nuclear transport mechanisms and nucleoporins (NUPs), the...

Full description

Saved in:
Bibliographic Details
Published inCell host & microbe Vol. 7; no. 3; pp. 221 - 233
Main Authors Lee, KyeongEun, Ambrose, Zandrea, Martin, Thomas D, Oztop, Ilker, Mulky, Alok, Julias, John G, Vandegraaff, Nick, Baumann, Joerg G, Wang, Rui, Yuen, Wendy, Takemura, Taichiro, Shelton, Kenneth, Taniuchi, Ichiro, Li, Yuan, Sodroski, Joseph, Littman, Dan R, Coffin, John M, Hughes, Stephen H, Unutmaz, Derya, Engelman, Alan, KewalRamani, Vineet N
Format Journal Article
LanguageEnglish
Published United States 18.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:HIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the retroviral preintegration complex (PIC), into the nucleus. Too large for passive diffusion through nuclear pore complexes (NPCs), PICs use cellular nuclear transport mechanisms and nucleoporins (NUPs), the NPC components that permit selective nuclear-cytoplasmic exchange, but the details remain unclear. Here we identify a fragment of the cleavage and polyadenylation factor 6, CPSF6, as a potent inhibitor of HIV-1 infection. When enriched in the cytoplasm, CPSF6 prevents HIV-1 nuclear entry by targeting the viral capsid (CA). HIV-1 harboring the N74D mutation in CA fails to interact with CPSF6 and evades the nuclear import restriction. Interestingly, whereas wild-type HIV-1 requires NUP153, N74D HIV-1 mimics feline immunodeficiency virus nuclear import requirements and is more sensitive to NUP155 depletion. These findings reveal a remarkable flexibility in HIV-1 nuclear transport and highlight a single residue in CA as essential in regulating interactions with NUPs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Equal contributions
Current Addresses: Z.A., Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA; T.D.M., MedImmune, One MedImmune Way, Gaithersburg, MD, 20841, USA; N.V., Avexa Limited, Richmond, Victoria 3121, Australia; J.G.B., Fraunhofer Institute for Cell Therapy and Immunology, Perlickstr. 1, D-04103 Leipzig, Germany; K.S., Department of Anesthesia & Critical Care, Massachusetts General Hospital, Boston, MA, 02114, USA.
ISSN:1934-6069
1931-3128
1934-6069
DOI:10.1016/j.chom.2010.02.007